71 related articles for article (PubMed ID: 9428921)
21. Identification of an immunogenic EWS-FLI1-derived HLA-DR-restricted T helper cell epitope.
Meyer-Wentrup F; Richter G; Burdach S
Pediatr Hematol Oncol; 2005 Jun; 22(4):297-308. PubMed ID: 16020117
[TBL] [Abstract][Full Text] [Related]
22. Two brc-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes.
Greco G; Fruci D; Accapezzato D; Barnaba V; Nisini R; Alimena G; Montefusco E; Vigneti E; Butler R; Tanigaki N; Tosi R
Leukemia; 1996 Apr; 10(4):693-9. PubMed ID: 8618449
[TBL] [Abstract][Full Text] [Related]
23. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.
Correale P; Walmsley K; Zaremba S; Zhu M; Schlom J; Tsang KY
J Immunol; 1998 Sep; 161(6):3186-94. PubMed ID: 9743387
[TBL] [Abstract][Full Text] [Related]
24. Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma.
Rodeberg DA; Nuss RA; Heppelmann CJ; Celis E
Cancer Immunol Immunother; 2005 Jun; 54(6):526-34. PubMed ID: 15838707
[TBL] [Abstract][Full Text] [Related]
25. A HLA-A2 restricted human CTL line recognizes a novel tumor cell expressed p53 epitope.
Würtzen PA; Claesson MH
Int J Cancer; 2002 Jun; 99(4):568-72. PubMed ID: 11992547
[TBL] [Abstract][Full Text] [Related]
26. Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognition.
Collins EJ; Booth BL; Cerundolo V
J Immunol; 1999 Jan; 162(1):331-7. PubMed ID: 9886403
[TBL] [Abstract][Full Text] [Related]
27. Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides.
Pala P; Corradin G; Strachan T; Sodoyer R; Jordan BR; Cerottini JC; Maryanski JL
J Immunol; 1988 Feb; 140(3):871-7. PubMed ID: 2448379
[TBL] [Abstract][Full Text] [Related]
28. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
Sensi M; Pietra G; Molla A; Nicolini G; Vegetti C; Bersani I; Millo E; Weiss E; Moretta L; Mingari MC; Anichini A
Int Immunol; 2009 Mar; 21(3):257-68. PubMed ID: 19181932
[TBL] [Abstract][Full Text] [Related]
29. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
Gricks CS; Rawlings E; Foroni L; Madrigal JA; Amlot PL
Cancer Res; 2001 Jul; 61(13):5145-52. PubMed ID: 11431353
[TBL] [Abstract][Full Text] [Related]
30. [The characteristics of anti-B-cell malignance cytotoxic T lymphocytic clones induced by lymphoma relative peptides].
Guo XL; Zhu P; Zhu X; Liu J; Ou Y; Du JW
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1476-80. PubMed ID: 16061026
[TBL] [Abstract][Full Text] [Related]
31. Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations.
Worley BS; van den Broeke LT; Goletz TJ; Pendleton CD; Daschbach EM; Thomas EK; Marincola FM; Helman LJ; Berzofsky JA
Cancer Res; 2001 Sep; 61(18):6868-75. PubMed ID: 11559563
[TBL] [Abstract][Full Text] [Related]
32. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
Kast WM; Brandt RM; Sidney J; Drijfhout JW; Kubo RT; Grey HM; Melief CJ; Sette A
J Immunol; 1994 Apr; 152(8):3904-12. PubMed ID: 7511661
[TBL] [Abstract][Full Text] [Related]
33. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes.
Clayberger C; Parham P; Rothbard J; Ludwig DS; Schoolnik GK; Krensky AM
Nature; 1987 Dec 24-31; 330(6150):763-5. PubMed ID: 3501071
[TBL] [Abstract][Full Text] [Related]
34. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
35. Alloreactivity as a source of high avidity peptide-specific human CTL.
Münz C; Obst R; Osen W; Stevanović S; Rammensee HG
J Immunol; 1999 Jan; 162(1):25-34. PubMed ID: 9886366
[TBL] [Abstract][Full Text] [Related]
36. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P
J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041
[TBL] [Abstract][Full Text] [Related]
37. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
38. Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1.
van Schravendijk MR; Biddison WE; Berger AE; Coligan JE
J Immunol; 1985 Jan; 134(1):410-6. PubMed ID: 3871112
[TBL] [Abstract][Full Text] [Related]
39. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
[TBL] [Abstract][Full Text] [Related]
40. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development.
Threlkeld SC; Wentworth PA; Kalams SA; Wilkes BM; Ruhl DJ; Keogh E; Sidney J; Southwood S; Walker BD; Sette A
J Immunol; 1997 Aug; 159(4):1648-57. PubMed ID: 9257824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
